HX

Health X Platform Ltd

Q2 FY27Healthcare Services

Health X Platform Q2 Results 2026: Net loss ₹13 Cr

Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹484Cr
+60.8% YoY
+8.3% QoQ
Net profit
−₹13Cr
Q2 FY26: −₹15 Cr
Margin
−4.6%
+3.4 pp YoY
−2.7 pp QoQ

Health X Platform Ltd Q2 FY27 key numbers

Revenue
Q2 FY27 revenue from operations: Rs 489.1 Cr, up 58.8% year-on-year.

As stated in Health X Platform Ltd's Q2 FY27 investor presentation · published 14 Nov 2026. Reported figures, not investment advice.

Based on Health X Platform Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹273
Market cap₹869 Cr

The short version

Q2 FY27 revenue from operations: Rs 489.1 Cr, up 58.8% year-on-year (Page 24). Quarterly EBITDA: Rs.

From Health X Platform Ltd's Q2 FY27 earnings-call transcript · updated 14 Nov 2026.

How did Health X Platform's revenue grow in the September 2026 quarter?

  • Q2 FY27 revenue from operations: Rs 489.1 Cr, up 58.8% year-on-year (Page 24).
  • Q1 FY27 revenue from operations: Rs 440.3 Cr, up 11.1% year-on-year (Page 24).
  • Q2 FY26 revenue from operations (comparable quarter last year): Rs 307.9 Cr (Page 24).
  • Retailer Shakti Q2 FY27 sales: Rs 428.9 Cr (Page 26).
  • SastaSundar Q2 FY27 sales: Rs 54.9 Cr (Page 26).

2 more points from Health X Platform Ltd's call on revenue

Create a free account to keep reading this call

What happened to Health X Platform's margins in Q2 FY27?

Quarterly EBITDA: Rs. (14.9) Cr, down from (78.9) Cr in previous quarter FY26, representing an EBITDA…

Locked: what Health X Platform Ltd said on margins

Also locked on this page: capex, fundraising, order book

Free account, 30 seconds. No card needed.

What capex is Health X Platform planning?

See what Health X Platform Ltd said on capital expenditure plans — free account, 30 seconds.

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 3
2Indegene
Rev 2Mar 1
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Is Health X Platform raising money or cutting debt?

The Historical Consolidated Balance Sheet (Page 29) shows borrowings and other financial liabilities over…

Locked: what Health X Platform Ltd said on fundraising

Also locked on this page: margins, capex, order book

Free account, 30 seconds. No card needed.

How big is Health X Platform's order book?

See what Health X Platform Ltd said on order book & pipeline — free account, 30 seconds.

Health X Platform Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Health X Platform Ltd Q2 FY27 results — key figures

Health X Platform Ltd Q2 FY27 reported results vs Q2 FY26, ₹ crore
₹ CrQ2 FY27Q2 FY26YoYQ1 FY27QoQ
Revenue484301+60.8%447+8.3%
Operating profit (EBITDA)-22-23—-8—
Operating margin-4.6%-8%+3.4 pp-1.9%-2.7 pp
Profit before tax-15-19—2-850%
Net profit (PAT)-13-15—2-750%
EPS (₹)-3.47-3.99—0.80-533.7%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹484 Cr, net loss ₹13 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

More Q2 FY27 results in Healthcare Services

All Q2 FY27 results | Healthcare Services rankings

Others in Healthcare Services this season

  • Chandan Healthca (Q2 FY27)

    Revenue from operations for the half year ended 30th September 2026 is ₹10,660.84 lakhs, compared to the previous year ended 31st March 2026 figure of…

  • Invicta Diagnostic (Q2 FY27)

    Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2

  • Unihealth Hosp (Q2 FY27)

    1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r

  • Sangani Hospital (Q2 FY27)

    1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Health X Platform Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Health X Platform Ltd Q2 FY27 results?

Q2 FY27 revenue from operations: Rs 489.1 Cr, up 58.8% year-on-year (Page 24). Quarterly EBITDA: Rs.

What is Health X Platform Ltd share price analysis?

Health X Platform Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹869 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Health X Platform Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.